Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,390,586 papers from all fields of science
Search
Sign In
Create Free Account
UD CG 115
Known as:
UD-CG 115
, UD-CG115
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
pimobendan
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2001
2001
Decrease in Ca(2+)-sensitizing effect of UD-CG 212 Cl, a metabolite of pimobendan, under acidotic condition in canine ventricular myocardium.
R. Takahashi
,
Y. Shimazaki
,
M. Endoh
Journal of Pharmacology and Experimental…
2001
Corpus ID: 9977613
We studied the influence of acidosis on the positive inotropic effect of UD-CG 212 Cl (4,5-dihydro-6-[2-(4-hydroxyphenyl)-1H…
Expand
1997
1997
Contribution of phosphodiesterase isozymes to the regulation of the L‐type calcium current in human cardiac myocytes
K. Kajimoto
,
N. Hagiwara
,
H. Kasanuki
,
S. Hosoda
British Journal of Pharmacology
1997
Corpus ID: 25522149
1 To determine the contribution of the various phosphodiesterase (PDE) isozymes to the regulation of the L‐type calcium current…
Expand
1995
1995
Low concentrations of UD-CG 212 enhance myocyte contractility by an increase in calcium responsiveness in the presence of inorganic phosphate
J. C. A. Meel
,
N. Redemann
,
W. Diederen
,
R. Haigh
Naunyn-Schmiedeberg's Archives of Pharmacology
1995
Corpus ID: 19282490
Recent data show that UD-CG 212 in nanomolar concentrations increases myofibrillar Ca++ responsiveness of chemically skinned…
Expand
1992
1992
Electrophysiological actions of the pimobendan metabolite, UD-CG 212 Cl, in guinea pig myocardium.
M. Westfall
,
G. Wahler
,
K. Fujino
,
R. Solaro
Journal of Pharmacology and Experimental…
1992
Corpus ID: 24799059
Pimobendan (UD-CG 115 BS), an inotropic agent and inhibitor of type III phosphodiesterase activity, is demethylated in vivo to…
Expand
1992
1992
抗心不全薬UD-CG115 BSカプセル(Pimobendan)の臨床薬理学的検討
林 博史
,
棚橋 淑文
,
+5 authors
中島 光好
1992
Corpus ID: 196276157
1991
1991
Different Mechanisms Involved in the Positive Inotropic Effects of Benzimidazole Derivative UD‐CG 115 BS (Pimobendan) and Its Demethylated Metabolite UD‐CG 212 Cl in Canine Ventricular Myocardium
M. Endoh
,
Takahisa Shibasaki
,
H. Satoh
,
I. Norota
,
A. Ishihata
Journal of Cardiovascular Pharmacology
1991
Corpus ID: 25067934
UD-CG 115 BS produced a positive inotropic effect in a concentration-dependent manner (EC50 – 9.2 × 10 -5 M, efficacy = 0.65) in…
Expand
1989
1989
Acute Effects of Intraveneous UD‐CG 115 BS (Pimobendan) on the Cardiovascular System and Left Ventricular Pump Function
B. Permanetter
,
H. Sebening
,
F. Hartmann
,
Gemot Klein
Journal of Cardiovascular Pharmacology
1989
Corpus ID: 26103249
Acute hemodynamic effects of 5 and 10 nig i.v. UD-CG 115 BS (pimobendan) were studied by right and left heart catheterization in…
Expand
1989
1989
Clinical Efficacy of Pimobendan (UD‐CG 115 BS) in Patients with Chronic Congestive Heart Failure
G. Baumann
,
K. Ningel
,
B. Permanetter
Journal of Cardiovascular Pharmacology
1989
Corpus ID: 28186586
The pyridazoline derivative UD-CG 115 BS (pimobendan) is a noneatecholamine. nonglyeoside new inotropic compound with potent…
Expand
1989
1989
Platelet aggregation inhibitory effects of the new positive inotropic agents pimobendan and UD CG 212 in whole blood.
A. Saniabadi
,
G. Lowe
,
J. Belch
,
C. Forbes
Cardiovascular Research
1989
Corpus ID: 24160138
A method is described for studying platelet function in human whole blood immediately after venepuncture in order to evaluate the…
Expand
1984
1984
UD-CG 115 — a cardiotonic pyridazinone which elevates cyclic AMP and prolongs the action potential in guinea-pig papillary muscle
P. Honerjäger
,
A. Heiss
,
M. Schäfer-Korting
,
G. Schönsteiner
,
M. Reiter
Naunyn-Schmiedeberg's Archives of Pharmacology
1984
Corpus ID: 13050976
Summary1.The mechanism of the positive inotropic effect of a benzimidazole-pyridazinone, UD-CG 115, was analysed in the isolated…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE